UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

January 9, 2004
- ------------------
(Date of earliest event reported)


LABORATORY CORPORATION OF AMERICA HOLDINGS
- ------------------------------------------
(Exact name of registrant as specified in its charter)


   DELAWARE                1-11353             13-3757370
 --------------          -----------         --------------
(State or other         (Commission          (IRS Employer
jurisdiction of         File Number)         Identification
incorporation)                                   Number)


358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215
- -------------------------------------------------------
(Address of principal executive offices)

336-229-1127
- ------------
(Registrant's telephone number, including area code)


ITEM 9. Regulation FD Disclosure

On January 9, 2004, Laboratory Corporation of America -Registered Trademark-
Holdings (LabCorp -Registered Trademark-)(NYSE:LH) announced that Bradford T.
Smith, executive vice president of corporate affairs, is scheduled to speak at
the 22nd Annual JPMorgan Healthcare Conference in San Francisco, CA on January
12, 2004 at 10:30 a.m. Pacific Time.  A live audio webcast of the presentation
will be available via the Company web site at www.labcorp.com  A replay of the
audio webcast will be available through April 12, 2004.




Exhibits:
99.1  Press release of the Company dated January 9, 2004.


SIGNATURES

Pursuant to the requirements of the Securities and
Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the
undersigned hereunto duly authorized.

          LABORATORY CORPORATION OF AMERICA HOLDINGS
          ------------------------------------------
                        (Registrant)

               By:/s/ BRADFORD T. SMITH
                  ----------------------------------
                      Bradford T. Smith
                      Executive Vice President
                      and Secretary


Date: January 12, 2004

EXHIBIT 99.1

Laboratory Corporation of America-Registered Trademark- Holdings
358 South Main Street
Burlington, NC   27215
Telephone:  (336) 584-5171

For Immediate Release:
Contact: Pamela Sherry - (336) 436-4855
Shareholder Direct: (800) LAB-0401
Company Information: www.Labcorp.com


LABCORP-REGISTERED TRADEMARK-SCHEDULED TO PRESENT
AT THE ANNUAL JPMORGAN HEALTHCARE CONFERENCE

Burlington, NC, January 9, 2004 - Laboratory Corporation of America-
Registered Trademark- Holdings (LabCorp-Registered Trademark-) (NYSE: LH)
today announced that Bradford T. Smith, executive vice president of corporate
affairs, is scheduled to speak at the 22nd Annual JPMorgan Healthcare
Conference in San Francisco, CA on January 12, 2004 at 10:30 a.m. Pacific
Time. A live audio webcast of the presentation will be available via the
Company web site at www.labcorp.com.  A replay of the audio webcast will be
available through April 12, 2004.

About LabCorp
Laboratory Corporation of America-Registered Trademark- Holdings is a pioneer
in commercializing new diagnostic technologies and the first in its industry
to embrace genomic testing. With annual revenues of $2.5 billion in 2002, over
24,000 employees nationwide, and more than 200,000 clients, LabCorp offers
over 4,000 clinical assays ranging from blood analyses to HIV and genomic
testing. LabCorp combines its expertise in innovative clinical testing
technology with its Centers of Excellence: The Center for Molecular Biology
and Pathology, in Research Triangle Park, NC; National Genetics Institute,
Inc. in Los Angeles, CA; ViroMed Laboratories, Inc. based in Minneapolis, MN;
The Center for Esoteric Testing in Burlington, NC; and DIANON Systems, Inc.
based in Stratford, CT.  LabCorp clients include physicians, government
agencies, managed care organizations, hospitals, clinical labs, and
pharmaceutical companies. To learn more about our growing organization, visit
our web site at: www.LabCorp.com.

Each of the above forward-looking statements is subject to change based on
various important factors, including without limitation, competitive actions
in the marketplace and adverse actions of governmental and other third-party
payors.  Actual results could differ materially from those suggested by these
forward-looking statements. Further information on potential factors that
could affect LabCorp's financial results is included in the Company's Form
10-K for the year ended December 31, 2002 and will be included in the
Company's form 10-K for the year ended December 31, 2003, when filed.